Valuation Shanghai Shyndec Pharmaceutical Co., Ltd.

Equities

End-of-day quote Shanghai S.E. Other stock markets 2024-09-06			5-day change	1st Jan Change
10.44 ^CNY	-3.24%		-7.77%	+6.64%

09-05	China Approves Shyndec Pharmaceutical's Listing Application for Epilepsy Drug Ingredient	MT
08-30	Shyndec Pharmaceutical Gets Nod to Add Specification to Pravastatin Sodium Tablets	MT

Fiscal Period: December	2022	2023	2024	2025	2026
Capitalization ¹	9,346	13,130	14,002	-	-
Change	-	40.5%	6.64%	-	-
Enterprise Value (EV)	9,346	13,130	14,002	14,002	14,002
Change	-	40.5%	6.64%	0%	0%
P/E ratio	14.9x	18x	11.6x	10.1x	9.16x
PBR	-	1.06x	1.08x	1.03x	0.98x
PEG	-	-1.6x	0.2x	0.7x	0.9x
Capitalization / Revenue	-	1.09x	1.14x	1.08x	1.03x
EV / Revenue	-	0x	1.14x	1.08x	1.03x
EV / EBITDA	-	-	-	-	-
EV / EBIT	-	-	-	-	-
EV / FCF	-	-	-	-	-
FCF Yield	-	-	-	-	-
Dividend per Share ²	-	0.1	1.8	2.05	2.27
Rate of return	-	1.02%	17.2%	19.6%	21.7%
EPS ²	0.6101	0.5433	0.9	1.03	1.14
Distribution rate	-	18.4%	200%	199%	199%
Net sales ¹	-	12,070	12,311	12,927	13,573
EBITDA	-	-	-	-	-
EBIT	-	-	-	-	-
Net income ¹	626.6	691.9	1,206	1,375	1,524
Net Debt	-	-	-	-	-
Reference price ²	9.10	9.79	10.44	10.44	10.44
Nbr of stocks (in thousands)	1,026,983	1,341,173	1,341,173	-	-
Announcement Date	23-01-13	24-03-29	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio	EV / Sales	EV / EBITDA	Yield (Y)	Capi. ($)
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	11.6x	-	-	+17.24%	1.98B
MERCK KGAA	24.55x	3.75x	13.26x	+1.37%	81.49B
KYOWA KIRIN CO. LTD.	24.75x	2.78x	11.77x	+1.82%	11.86B
YUHAN CORPORATION	62.15x	4.56x	53.85x	+0.33%	7.12B
SK BIOPHARMACEUTICALS CO., LTD.	115.27x	15.17x	82.99x	-.--%	6.12B
BETTA PHARMACEUTICALS CO., LTD.	32.19x	5.82x	18.07x	+0.70%	2.2B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	30.71x	-	-	-	1.94B
SUPERNUS PHARMACEUTICALS, INC.	116.69x	-	-	-	1.86B
INDIVIOR PLC	10.77x	1.08x	3.77x	-.--%	1.37B
Average	47.63x	5.53x	30.62x	+3.07%	12.88B
Weighted average by Cap.	33.02x	4.34x	19.58x	+1.52%